Sara Guerra

Sara Guerra

Auto-generated profile, based on publicly available information

Sara Guerra

Biophysics Unit, Faculty of Medicine, University of Coimbra, Azinhaga de Santa Comba - Celas, 3000-548, Coimbra, Portugal

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
MHMartina Theresa Hackl
Martina Theresa Hackl
CFClemens Fürnsinn
Clemens Fürnsinn
CSChristina Maria Schuh
Christina Maria Schuh
Martin KrssakMartin Krssak
Martin Krssak
FCFabrizia Carli
Fabrizia Carli
TSThomas Scherer
Thomas Scherer
Hepatic steatosis develops when lipid influx and production exceed the liver’s ability to utilize/export triglycerides. Obesity promotes steatosis and is characterized by leptin resistance. A role of leptin in hepatic lipid handling is highlighted by the observation that recombinant leptin reverses steatosis of hypoleptinemic patients with lipodystrophy by an unknown mechanism. Since leptin mainly functions via CNS signaling, we here examine in rats whether leptin regulates hepatic lipid flux via the brain in a series of stereotaxic infusion experiments. We demonstrate that brain leptin protects from steatosis by promoting hepatic triglyceride export and decreasing de novo lipogenesis independently of caloric intake. Leptin’s anti-steatotic effects are generated in the dorsal vagal complex, require hepatic vagal innervation, and are preserved in high-fat-diet-fed rats when the blood brain barrier is bypassed. Thus, CNS leptin protects from ectopic lipid accumulation via a brain-vagus-liver axis and may be a therapeutic strategy to ameliorate obesity-related steatosis.


25 October 2021 in European Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
SGSara Guerra
Sara Guerra
GMGabriele Mocciaro
Gabriele Mocciaro
Amalia GastaldelliAmalia Gastaldelli
Amalia Gastaldelli
Background: The prevalence of non‐alcoholic fatty liver disease (NAFLD) is now 25% in the general population but increases to more than 55% in subjects with obesity and/or type 2 diabetes. Simple steatosis (NAFL) can develop into more severe forms, that is non‐alcoholic steatohepatitis (NASH), cirrhosis and hepatocellular carcinoma leading to death.Methods: In this narrative review, we have discussed the current knowledge in the pathophysiology of fatty liver disease, including both metabolic and non‐metabolic factors, insulin resistance, mitochondrial function, as well as the markers of liver damage, giving attention to the alterations in lipid metabolism and production of lipotoxic lipids.Results: Insulin resistance, particularly in the adipose tissue, is the main driver of NAFLD due to the excess release of fatty acids. Lipidome analyses have shown that several lipids, including DAGs and ceramides, and especially if they contain saturated lipids, act as bioactive compounds, toxic to the cells. Lipids can also affect mitochondrial function. Not only lipids, but also amino acid metabolism is impaired in NAFL/NASH, and some amino acids, as branched‐chain and aromatic amino acids, glutamate, serine and glycine, have been linked to impaired metabolism, insulin resistance and severity of NAFLD and serine is a precursor of ceramides.Conclusions: The measurement of lipotoxic species and adipose tissue dysfunction can help to identify individuals at risk of progression to NASH.

27 October 2015 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
AMA. C. Mamede
A. C. Mamede
SGS. Guerra
S. Guerra
Mafalda LaranjoMafalda Laranjo
Mafalda Laranjo
MCMaria João Carvalho
Maria João Carvalho
Rui Caetano OliveiraRui Caetano Oliveira
Rui Caetano Oliveira
Maria Filomena BotelhoMaria Filomena Botelho
Maria Filomena Botelho

10 March 2016 in Pathology and Oncology Research
Verified
Journal Article
Closed access
PDF file
AMA. C. Mamede
A. C. Mamede
SGS. Guerra
S. Guerra
Mafalda LaranjoMafalda Laranjo
Mafalda Laranjo
KSK. Santos
K. Santos
MCMaria João Carvalho
Maria João Carvalho
Maria Filomena BotelhoMaria Filomena Botelho
Maria Filomena Botelho

22 August 2016 in Cell and Tissue Banking
Verified
Journal Article
Closed access
PDF file
SGSara Guerra
Sara Guerra
AMAna Catarina Mamede
Ana Catarina Mamede
MCMaria João Carvalho
Maria João Carvalho
Mafalda LaranjoMafalda Laranjo
Mafalda Laranjo
José Guilherme TralhãoJosé Guilherme Tralhão
José Guilherme Tralhão
Maria Filomena BotelhoMaria Filomena Botelho
Maria Filomena Botelho